With an aging population, the magnitude of the public
health threat posed by osteoporosis continues to increase.
The National Osteoporosis Foundation has estimated that in
the US, 10 million individuals already have the disease and
almost 34 million more have low bone mass. The overall goal in the management of patients who have
been diagnosed with or are at risk for osteoporosis is
fracture prevention. The results of randomized controlled
trials provide evidence-based information to guide clinicians
in choosing effective therapies. Although bone mass remains
the primary risk factor for fractures, clinicians should
recognize that other factors contribute to fracture risk.
The AMA is pleased to provide a state-of-the-art program
that reviews the most current clinical trial data and
professional guidelines pertaining to bone mineral density
testing, the use of bone turnover markers, the prevention
and treatment of osteoporosis in men and women, and
glucocorticoid-induced osteoporosis.
The American Medical Association is accredited by the
Accreditation Council for Continuing Medical Education
(ACCME) to provide continuing medical education for
physicians.
The American Medical Association designates this educational
activity for a maximum of 18 AMA PRA Category 1
Credits™. Physicians
should only claim credit commensurate with the extent
of their participation in the activity.
Nonphysicians may receive a certificate of participation
for completing this activity.
Release date: December, 2004
Expiration date: December, 2006
|
